JOINN Biologics

About:

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.

Website: https://www.joinnbio.com

Top Investors: CPE, Green Pine Capital Partners, Yingke Capital, Hongtai Capital Holdings, HT Capital

Description:

JOINN Biologics is a California Bay Area-based company that is committed to the advancement of biotech and biopharmaceutics through our premier contract manufacturing and development services for biologics and advanced therapies. A vital part of the JOINN Family's successful 20+ year track record of supporting drug discovery and development, we provide a complete range of CDMO services, from early development to clinical manufacturing, for our clients and partners on a global scale. Core Capabilities • Molecular/developability assessment • cGMP clinical trial materials production • Commercial-scale cGMP manufacturing • Non-GMP protein expression and purification • Cell line development • Upstream process development • Downstream purification development • Analytical and formulation development • Documentation and reporting to support regulatory filings Mission It is our mission to provide our global clients and partners with a complete range of premier contract development and manufacturing services for biologics and advanced therapies, from early custom development to clinical manufacturing, to further accelerate the development of high-quality biologics, meeting patients' needs and delivering long-lasting value to the biotech and biopharmaceutical industry.

Total Funding Amount:

$210M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Richmond, California, United States

Founded Date:

2018-05-01

Contact Email:

info(AT)joinnbio.com

Founders:

Shusheng Geng, Tao He

Number of Employees:

51-100

Last Funding Date:

2021-08-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai